About ApredicaApredica is the oldest early-ADME/Tox contract research lab in New England. On August 4, 2010 Apredica acquired the High Content Toxicology intellectual property and other assets from Cellumen. On August 6, 2010 Apredica was acquired by the UK-based ADME Tox contract research organization Cyprotex. Our mission is to provide the benefits of outsourced early ADME/Tox analysis with the same speed and service quality provided by an in-house service department. We combine the flexibility, expertise, and low cost of outsourcing with the speed and scientist-to-scientist communications of insourcing. Apredica founders are Katherine Tsaioun and Doug Bates. Our NameApredica is pronounced a like "america" (ah-PRED-ik-ah). It is derived from ADME predictive assays. Our Facilities
Our Equipment
Our StaffEach member of Apredica's scientific team has more than 10 years' drug-discovery experience. 80% of our scientific staff have Ph.D.s. Meet our team. Memberships  LegalApredica is a Delaware incorporated LLC. Please email corporate@apredica.com regarding any legal matter. |
Apredica is located in a 4,400 square foot facility at 313 Pleasant St., Watertown, MA.